Ron Lillie is currently Director, Drug Safety Data Analytics at Exelixis, Inc. a biopharmaceutical company based in Alameda, California, which develops and markets oncology products. He brings over 20 years of experience within the pharmaceutical industry in Clinical Development and Software Applications in the areas of eClinical, Pharmacovigilance, Signal Detection & Management, and Medical Information. In his current role he supports the Signal & Risk Management and Drug Safety Operations teams through development and implementation of Analytical and Visualization applications. In additional current roles, he manages software development and process-related projects in partnership with vendors, manages vendor and software selection programs, and is responsible for vendor relationship management. Ron is a graduate of Johns Hopkins University with an M.S. in Technical Management (Innovation focus), and the University of Toronto with a B.Sc. in Human Biology (Neuroscience focus). He is currently a doctoral candidate in Regulatory Sciences in the School of Pharmacy at the University of Southern California.